Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinib
Baijun Fang, Ning Li, Yongping Song, Qin Han, Robert Chunhua ZhaoVolume:
89
Language:
english
Pages:
7
DOI:
10.1007/s00277-010-0991-4
Date:
November, 2010
File:
PDF, 127 KB
english, 2010